
Use of biologic or targeted-synthetic disease-modifying anti-rheumatic drugs and risk of diabetes treatment intensification in patients with rheumatoid arthritis and diabetes mellitus
Chen, Sarah K, Lee, Hemin, Jin, Yinzhu, Liu, Jun, Kim, Seoyoung CVolume:
4
Journal:
Rheumatology Advances in Practice
DOI:
10.1093/rap/rkaa027
Date:
July, 2020
Fichier:
PDF, 261 KB
2020